Wolfe JD - Search Results

1

Comparison of the acute cardiopulmonary effects of oral albuterol, metaproterenol, and terbutaline in asthmatics.

Wolfe JD, Yamate M, Biedermann AA, Chu TJ. Wolfe JD, et al. JAMA. 1985 Apr 12;253(14):2068-72. JAMA. 1985. PMID: 3974097 Clinical Trial.

2

Once versus twice daily dosing of terfenadine in the treatment of seasonal allergic rhinitis: US and European studies.

Chu TJ, Yamate M, Biedermann AA, Wolfe JD, Goldsobel AB. Chu TJ, et al. Among authors: wolfe jd. Ann Allergy. 1989 Dec;63(6 Pt 2):612-5. Ann Allergy. 1989. PMID: 2574554 Clinical Trial.

3

Comparison of albuterol and metaproterenol syrup in the treatment of childhood asthma.

Wolfe JD, Shapiro GG, Ratner PH. Wolfe JD, et al. Pediatrics. 1991 Aug;88(2):312-9. Pediatrics. 1991. PMID: 1861931 Clinical Trial.

4

Salmeterol powder compared with albuterol aerosol as maintenance therapy for asthma in adolescent and adult patients.

Kemp J, Wolfe J, Grady J, LaForce C, Stahl E, Arledge T, Liddle R. Kemp J, et al. Clin Ther. 1998 Mar-Apr;20(2):270-82. doi: 10.1016/s0149-2918(98)80090-8. Clin Ther. 1998. PMID: 9589818 Clinical Trial.

5

Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma.

Wolfe J, Kreitzer S, Chervinsky P, Lawrence M, Wang Y, Reilly D, Davis S, Stahl E. Wolfe J, et al. Ann Allergy Asthma Immunol. 2000 Mar;84(3):334-40. doi: 10.1016/S1081-1206(10)62783-4. Ann Allergy Asthma Immunol. 2000. PMID: 10752919 Clinical Trial.

6

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.

Busse W, Nelson H, Wolfe J, Kalberg C, Yancey SW, Rickard KA. Busse W, et al. J Allergy Clin Immunol. 1999 Jun;103(6):1075-80. doi: 10.1016/s0091-6749(99)70182-x. J Allergy Clin Immunol. 1999. PMID: 10359889 Clinical Trial.

7

Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity.

Lawrence M, Wolfe J, Webb DR, Chervinsky P, Kellerman D, Schaumberg JP, Shah T. Lawrence M, et al. Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):744-51. doi: 10.1164/ajrccm.156.3.9608058. Am J Respir Crit Care Med. 1997. PMID: 9309988 Clinical Trial.

8

Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.

Wolfe J, Rooklin A, Grady J, Munk ZM, Stevens A, Prillaman B, Duke S, Harding S. Wolfe J, et al. J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1153-61. doi: 10.1067/mai.2000.107037. J Allergy Clin Immunol. 2000. PMID: 10856150 Clinical Trial.

9

LONG-TERM USE OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Begaj T, Jeong D, Park JG, Runner MM, Capone A Jr, Dass AB, Drenser KA, Faia LJ, Farley ND, Garretson BR, Hassan TS, Mahmoud TH, Margherio A, Raphaelian PV, Randhawa S, Ruby AJ, Sneed S, Rao P, Wolfe JD, Williams GA. Begaj T, et al. Among authors: wolfe jd. Retina. 2024 Feb 1;44(2):222-229. doi: 10.1097/IAE.0000000000003961. Retina. 2024. PMID: 37903288

10

Surgical Management of Full-Thickness Macular Holes in Macular Telangiectasia Type 2: A Global Multicenter Study.

Park JG, Adrean SD, Begaj T, Capone A Jr, Charles S, Chen SN, Chou HD, Cohen MN, Corona ST, Faia LJ, Garg SJ, Garretson BR, Gregori NZ, Haller JA, Houghton OM, Hsu J, Jo J, Kaiser RS, Lai CC, Mahgoub MM, Mansoor M, Matoba R, Morizane Y, Nehemy MB, Raphaelian PV, Regillo CD, Ruby AJ, Runner MM, Sneed SR, Sohn EH, Spirn MJ, Vander JF, Wakabayashi T, Wolfe JD, Wykoff CC, Yonekawa Y, Yoon YH, Mahmoud TH. Park JG, et al. Among authors: wolfe jd. Ophthalmology. 2024 Jan;131(1):66-77. doi: 10.1016/j.ophtha.2023.08.025. Epub 2023 Sep 3. Ophthalmology. 2024. PMID: 37661066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page